Research NewsBiotechnology

Antisense Aims for a Renaissance

See allHide authors and affiliations

Science  23 May 1997:
Vol. 276, Issue 5316, pp. 1192-1193
DOI: 10.1126/science.276.5316.1192

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


CAMBRIDGE, MASSACHUSETTS-- Once plagued by side effects and mysterious failures, antisense technologies are now shedding their troubled image. Basic research has uncovered explanations--and solutions--to some of the earlier problems, and antisense drugs have shown promise in early clinical trials against cancer and Crohn's disease.